Evidence map›Paper›PMID 23936575›Full record

ArticlePLoS neglected tropical diseases2013

Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal.

Richelle C Charles, Tania Sultana, Mohammad Murshid Alam, Yanan Yu, Ying Wu-Freeman, Meagan Kelly Bufano, Sean M Rollins, Lillian Tsai, Jason B Harris, Regina C LaRocque and 12 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 52 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Estimating enteric fever seroincidence in Bangladesh using rapid serosurveys.medRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Seroincidence of Enteric Fever, Juba, South Sudan.Emerging infectious diseases · 2022
    Article
  13. Article
  14. Computational analysis and prediction of PE_PGRS proteins using machine learning.Computational and structural biotechnology journal · 2022
    Article
  15. Review
  16. Article
  17. PE_PGRS proteins ofVirulence · 2020
    Review
  18. Article
  19. Article
  20. Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 8 institutions in 5 countries.

Richelle C CharlesDivision of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA. rccharles@partners.org
Tania Sultana
Mohammad Murshid Alam
Yanan Yu
Ying Wu-Freeman
Meagan Kelly Bufano
Sean M Rollins
Lillian Tsai
Jason B Harris
Regina C LaRocque
Daniel T Leung
W Abdullah Brooks
Tran Vu Thieu Nga
Sabina Dongol
Buddha Basnyat
Stephen B Calderwood
Jeremy Farrar
Farhana Khanam
John S Gunn
Firdausi Qadri
Stephen Baker
Edward T Ryan
Massachusetts General Hospital · USInternational Centre for Diarrhoeal Disease Research · BDHarvard University · USPatan Academy of Health Sciences · NPHospital for Tropical Diseases · VNInterface (United States) · USNuffield Orthopaedic Centre · GBUniversity of Oxford · GB

Funding

Fogarty International Clinical Research Scholars Support Center @ Vanderbilt-AAMCR24TW007988 · FIC · VANDERBILT UNIVERSITY · PI VERMUND, STEN H. · 2007 to 2011
$27.6M
Protecutive immunity to human cholera in BangladeshU01AI058935 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CALDERWOOD, STEPHEN B., RYAN, EDWARD T. · 2003 to 2014
$7.8M
High throughput NAPPA-proteoimmunomics and Vibrio cholerae vaccine developmentU01AI077883 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2008 to 2012
$5.6M
Training program in vaccine development and public healthD43TW005572 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI QADRI, FIRDAUSI, RYAN, EDWARD T. · 2000 to 2025
$5.4M
Improving diagnostic capabilities for typhoid feverR33AI100023 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2014 to 2016
$987k
The role of TcpA in cholera immunity and vaccinationK01TW007409 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI HARRIS, JASON B · 2005 to 2011
$867k
Immune Responses to Vibrio Cholerae in ChildrenK08AI100923 · NIAID · UNIVERSITY OF UTAH · PI LEUNG, DANIEL TED · 2012 to 2016
$686k
High-throughput proteomic study of protective immunity in human cholera infectionK08AI089721 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI CHARLES, RICHELLE C · 2010 to 2014
$684k
Identification of human gene polymorphisms related to Vibrio cholerae infectionK01TW007144 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI LAROCQUE, REGINA C · 2004 to 2009
$617k
Improving diagnostic capabilities for typhoid feverR21AI100023 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2012 to 2013
$476k
FIC NIH HHS D43 TW005572FIC NIH HHS K01 TW007144FIC NIH HHS K01 TW007409FIC NIH HHS K01 TW07144FIC NIH HHS K01 TW07409FIC NIH HHS R24 TW007988FIC NIH HHS TW005572Howard Hughes Medical InstituteNIAID NIH HHS AI058935NIAID NIH HHS AI077883NIAID NIH HHS AI100023NIAID NIH HHS K08 AI089721NIAID NIH HHS K08 AI100923NIAID NIH HHS R21 AI100023NIAID NIH HHS R33 AI100023NIAID NIH HHS U01 AI058935NIAID NIH HHS U01 AI077883Wellcome Trust 089276Wellcome Trust 100087
6 · The paper itself

Abstract

backgroundSalmonella enterica serotype Typhi can colonize and persist in the biliary tract of infected individuals, resulting in a state of asymptomatic chronic carriage. Chronic carriers may act as persistent reservoirs of infection within a community and may introduce infection to susceptible individuals and new communities. Little is known about the interaction between the host and pathogen in the biliary tract of chronic carriers, and there is currently no reliable diagnostic assay to identify asymptomatic S. Typhi carriage. METHODOLOGY/PRINCIPAL

findingsTo study host-pathogen interactions in the biliary tract during S. Typhi carriage, we applied an immunoscreening technique called in vivo-induced antigen technology (IVIAT), to identify potential biomarkers unique to carriers. IVIAT identifies humorally immunogenic bacterial antigens expressed uniquely in the in vivo environment, and we hypothesized that S. Typhi surviving in the biliary tract of humans may express a distinct antigenic profile. Thirteen S. Typhi antigens that were immunoreactive in carriers, but not in healthy individuals from a typhoid endemic area, were identified. The identified antigens included a number of putative membrane proteins, lipoproteins, and hemolysin-related proteins. YncE (STY1479), an uncharacterized protein with an ATP-binding motif, gave prominent responses in our screen. The response to YncE in patients whose biliary tract contained S. Typhi was compared to responses in patients whose biliary tract did not contain S. Typhi, patients with acute typhoid fever, and healthy controls residing in a typhoid endemic area. Seven of 10 (70%) chronic carriers, 0 of 8 bile culture-negative controls (0%), 0 of 8 healthy Bangladeshis (0%), and 1 of 8 (12.5%) Bangladeshis with acute typhoid fever had detectable anti-YncE IgG in blood. IgA responses were also present. CONCLUSIONS/SIGNIFICANCE: Further evaluation of YncE and other antigens identified by IVIAT could lead to the development of improved diagnostic assays to identify asymptomatic S. Typhi carriers.

Indexed as

Host-Pathogen InteractionsAdultAntigens, BacterialBiliary TractCarrier StateChildChild, PreschoolGene Expression ProfilingHumansNepalSalmonella typhiTyphoid FeverAntigens, Bacterial

Identifiers

PMID23936575
PMCPMC3731212
OpenAlexW2154149210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.